Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous...
SVT patients bear “significant risk” of thromboembolic complications at three months, despite anticoagulation
Despite a high rate of initial anticoagulation, patients with isolated superficial vein thrombosis (SVT) are at risk of thromboembolic complications—including recurrent or extended SVT...
Iliac vein stenting for chronic venous obstruction “significantly” improves venous disease-specific quality of life
Venous disease-specific quality of life (QoL), as measured by the VEINES (Venous insufficiency epidemiological and economic study)-QoL/Sym, improves significantly after iliac vein stenting for...
Thrombolex receives enhanced indication for use from the FDA
The US Food and Drug Administration (FDA) has enhanced the indications for use of the Bashir endovascular catheter (Thrombolex) and the Bashir Plus endovascular...
